Scientific Reports-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2125935, encodeId=18f121259355f, content=指派编辑以后Peer review要几天呢？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Fri Apr 14 16:32:58 CST 2023, time=2023-04-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=600264, encodeId=c43f6002643b, content=经验分享：去年12月初投稿，一审近2个月，大修，3位审稿专家提了好几个问题，都很专业，补了2个实验，没有办法补的实验就解释了一下。疫情原因试剂盒到位慢，申请延期1个月，二审1个半月，直接接收。一审二审都有形式审查，大约在投稿后一周左右给第一作者邮件反馈。decision letter直接发给通讯作者，其他作者看不到。另，感觉该杂志现在并不容易发表，审稿人问题有的也很尖锐，不知道为什么大家对它有偏见？这次遇到的审稿专家都还nice，没再让修改，心存感激。以上仅为个人观点，供大家参考，祝好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=482, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/59f804c69cf94ad1ab29dcfd6d74999a/ba623a930dae4fd7a8548c91ceb5dfcf.jpg, createdBy=82a72227743, createdName=meimary, createdTime=Sun May 24 12:13:23 CST 2020, time=2020-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218426, encodeId=06fb1218426a6, content=请教各位，进入Amendment requested状态，通讯作者没有收到修改的邮件，给编辑发邮件询问已经过去四天了，没有回复，系统给了十天修改，还剩五天了。请问有没有人遇到这种情况的，到底怎么解决，我看期刊给的有个电话，有人打过这个电话吗？马上面临毕业了，非常着急！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b155628254, createdName=ms2000000426385162, createdTime=Tue May 10 12:55:16 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203369, encodeId=7080120336979, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：乳腺癌;生信 经验分享：各位大神，你们的Response letter提交后多久有消息啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c4a02291457, createdName=wjsw123, createdTime=Thu Mar 17 09:24:21 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946858, encodeId=cb0994685829, content=proof后一般多久出版？我的两周了没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11753055294, createdName=gzbh, createdTime=Tue Mar 09 17:50:13 CST 2021, time=2021-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2178836, encodeId=212721e883660, content=偏重的研究方向：生物信息学;肿瘤;Cancer 经验分享：- [ ] 2023.12.26 submission received - [ ] 2023.12.26 submission is under technical check - [ ] 2023.12.27 submission passed technical check - [ ] 2023.12.27 editor invited - [ ] 2023.12.27 editor assigned - [ ] 2023.12.27 reviewers invited(3) - [ ] 2023.12.27 1 reviewer(s) accepted - [ ] 2023.12.30 2 reviewer(s) accepted (Awaiting their report), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240102/21c3548d3cdf4d768708708330c1b141/805c04b8c592400eb28358eb81f1a145.jpg, createdBy=4a299119890, createdName=Dehors, createdTime=Tue Jan 02 18:33:59 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2189047, encodeId=5931218904edb, content=偏重的研究方向：生物信息学 经验分享：<a href='/topic/show?id=8d82e952353' target=_blank style='color:#2F92EE;'>#网络药理学#</a>一个审稿人，等待编辑决定中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=12, topicName=null, topicId=null, topicList=[TopicDto(id=79523, encryptionId=8d82e952353, topicName=网络药理学)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae475506057, createdName=zll2020, createdTime=Sat Feb 24 11:25:52 CST 2024, time=2024-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190100, encodeId=2ddb2190100ee, content=Ready to be assigned to an editor这个是啥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cdc09126193, createdName=ms2000000089409289, createdTime=Thu Feb 29 14:55:03 CST 2024, time=2024-02-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2146816, encodeId=a52d21468164a, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：这个杂志真是个神，1月投稿，4月拿到一个审稿人意见，然后现在7月了，还是一个审稿人，额，6个月了，就这，不知道要多久，催了也没用，这杂志牛的，我估计年底给我意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95fa1958473, createdName=presson, createdTime=Fri Jul 07 16:01:50 CST 2023, time=2023-07-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1234686, encodeId=c069123468672, content=1 Reviewer report received一般要等多久啊。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2665416535, createdName=一路同行, createdTime=Mon Jul 25 19:49:16 CST 2022, time=2022-07-25, status=1, ipAttribution=)]

2023-04-14 ms7000000431018817 来自天津

指派编辑以后Peer review要几天呢？

72 13

展开13条回复

[GetPortalCommentsPageByObjectIdResponse(id=2125935, encodeId=18f121259355f, content=指派编辑以后Peer review要几天呢？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Fri Apr 14 16:32:58 CST 2023, time=2023-04-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=600264, encodeId=c43f6002643b, content=经验分享：去年12月初投稿，一审近2个月，大修，3位审稿专家提了好几个问题，都很专业，补了2个实验，没有办法补的实验就解释了一下。疫情原因试剂盒到位慢，申请延期1个月，二审1个半月，直接接收。一审二审都有形式审查，大约在投稿后一周左右给第一作者邮件反馈。decision letter直接发给通讯作者，其他作者看不到。另，感觉该杂志现在并不容易发表，审稿人问题有的也很尖锐，不知道为什么大家对它有偏见？这次遇到的审稿专家都还nice，没再让修改，心存感激。以上仅为个人观点，供大家参考，祝好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=482, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/59f804c69cf94ad1ab29dcfd6d74999a/ba623a930dae4fd7a8548c91ceb5dfcf.jpg, createdBy=82a72227743, createdName=meimary, createdTime=Sun May 24 12:13:23 CST 2020, time=2020-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218426, encodeId=06fb1218426a6, content=请教各位，进入Amendment requested状态，通讯作者没有收到修改的邮件，给编辑发邮件询问已经过去四天了，没有回复，系统给了十天修改，还剩五天了。请问有没有人遇到这种情况的，到底怎么解决，我看期刊给的有个电话，有人打过这个电话吗？马上面临毕业了，非常着急！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b155628254, createdName=ms2000000426385162, createdTime=Tue May 10 12:55:16 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203369, encodeId=7080120336979, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：乳腺癌;生信 经验分享：各位大神，你们的Response letter提交后多久有消息啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c4a02291457, createdName=wjsw123, createdTime=Thu Mar 17 09:24:21 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946858, encodeId=cb0994685829, content=proof后一般多久出版？我的两周了没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11753055294, createdName=gzbh, createdTime=Tue Mar 09 17:50:13 CST 2021, time=2021-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2178836, encodeId=212721e883660, content=偏重的研究方向：生物信息学;肿瘤;Cancer 经验分享：- [ ] 2023.12.26 submission received - [ ] 2023.12.26 submission is under technical check - [ ] 2023.12.27 submission passed technical check - [ ] 2023.12.27 editor invited - [ ] 2023.12.27 editor assigned - [ ] 2023.12.27 reviewers invited(3) - [ ] 2023.12.27 1 reviewer(s) accepted - [ ] 2023.12.30 2 reviewer(s) accepted (Awaiting their report), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240102/21c3548d3cdf4d768708708330c1b141/805c04b8c592400eb28358eb81f1a145.jpg, createdBy=4a299119890, createdName=Dehors, createdTime=Tue Jan 02 18:33:59 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2189047, encodeId=5931218904edb, content=偏重的研究方向：生物信息学 经验分享：<a href='/topic/show?id=8d82e952353' target=_blank style='color:#2F92EE;'>#网络药理学#</a>一个审稿人，等待编辑决定中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=12, topicName=null, topicId=null, topicList=[TopicDto(id=79523, encryptionId=8d82e952353, topicName=网络药理学)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae475506057, createdName=zll2020, createdTime=Sat Feb 24 11:25:52 CST 2024, time=2024-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190100, encodeId=2ddb2190100ee, content=Ready to be assigned to an editor这个是啥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cdc09126193, createdName=ms2000000089409289, createdTime=Thu Feb 29 14:55:03 CST 2024, time=2024-02-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2146816, encodeId=a52d21468164a, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：这个杂志真是个神，1月投稿，4月拿到一个审稿人意见，然后现在7月了，还是一个审稿人，额，6个月了，就这，不知道要多久，催了也没用，这杂志牛的，我估计年底给我意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95fa1958473, createdName=presson, createdTime=Fri Jul 07 16:01:50 CST 2023, time=2023-07-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1234686, encodeId=c069123468672, content=1 Reviewer report received一般要等多久啊。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2665416535, createdName=一路同行, createdTime=Mon Jul 25 19:49:16 CST 2022, time=2022-07-25, status=1, ipAttribution=)]

2020-05-24 meimary

经验分享：去年12月初投稿，一审近2个月，大修，3位审稿专家提了好几个问题，都很专业，补了2个实验，没有办法补的实验就解释了一下。疫情原因试剂盒到位慢，申请延期1个月，二审1个半月，直接接收。一审二审都有形式审查，大约在投稿后一周左右给第一作者邮件反馈。decision letter直接发给通讯作者，其他作者看不到。另，感觉该杂志现在并不容易发表，审稿人问题有的也很尖锐，不知道为什么大家对它有偏见？这次遇到的审稿专家都还nice，没再让修改，心存感激。以上仅为个人观点，供大家参考，祝好运！

482 13

展开13条回复

[GetPortalCommentsPageByObjectIdResponse(id=2125935, encodeId=18f121259355f, content=指派编辑以后Peer review要几天呢？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Fri Apr 14 16:32:58 CST 2023, time=2023-04-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=600264, encodeId=c43f6002643b, content=经验分享：去年12月初投稿，一审近2个月，大修，3位审稿专家提了好几个问题，都很专业，补了2个实验，没有办法补的实验就解释了一下。疫情原因试剂盒到位慢，申请延期1个月，二审1个半月，直接接收。一审二审都有形式审查，大约在投稿后一周左右给第一作者邮件反馈。decision letter直接发给通讯作者，其他作者看不到。另，感觉该杂志现在并不容易发表，审稿人问题有的也很尖锐，不知道为什么大家对它有偏见？这次遇到的审稿专家都还nice，没再让修改，心存感激。以上仅为个人观点，供大家参考，祝好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=482, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/59f804c69cf94ad1ab29dcfd6d74999a/ba623a930dae4fd7a8548c91ceb5dfcf.jpg, createdBy=82a72227743, createdName=meimary, createdTime=Sun May 24 12:13:23 CST 2020, time=2020-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218426, encodeId=06fb1218426a6, content=请教各位，进入Amendment requested状态，通讯作者没有收到修改的邮件，给编辑发邮件询问已经过去四天了，没有回复，系统给了十天修改，还剩五天了。请问有没有人遇到这种情况的，到底怎么解决，我看期刊给的有个电话，有人打过这个电话吗？马上面临毕业了，非常着急！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b155628254, createdName=ms2000000426385162, createdTime=Tue May 10 12:55:16 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203369, encodeId=7080120336979, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：乳腺癌;生信 经验分享：各位大神，你们的Response letter提交后多久有消息啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c4a02291457, createdName=wjsw123, createdTime=Thu Mar 17 09:24:21 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946858, encodeId=cb0994685829, content=proof后一般多久出版？我的两周了没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11753055294, createdName=gzbh, createdTime=Tue Mar 09 17:50:13 CST 2021, time=2021-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2178836, encodeId=212721e883660, content=偏重的研究方向：生物信息学;肿瘤;Cancer 经验分享：- [ ] 2023.12.26 submission received - [ ] 2023.12.26 submission is under technical check - [ ] 2023.12.27 submission passed technical check - [ ] 2023.12.27 editor invited - [ ] 2023.12.27 editor assigned - [ ] 2023.12.27 reviewers invited(3) - [ ] 2023.12.27 1 reviewer(s) accepted - [ ] 2023.12.30 2 reviewer(s) accepted (Awaiting their report), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240102/21c3548d3cdf4d768708708330c1b141/805c04b8c592400eb28358eb81f1a145.jpg, createdBy=4a299119890, createdName=Dehors, createdTime=Tue Jan 02 18:33:59 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2189047, encodeId=5931218904edb, content=偏重的研究方向：生物信息学 经验分享：<a href='/topic/show?id=8d82e952353' target=_blank style='color:#2F92EE;'>#网络药理学#</a>一个审稿人，等待编辑决定中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=12, topicName=null, topicId=null, topicList=[TopicDto(id=79523, encryptionId=8d82e952353, topicName=网络药理学)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae475506057, createdName=zll2020, createdTime=Sat Feb 24 11:25:52 CST 2024, time=2024-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190100, encodeId=2ddb2190100ee, content=Ready to be assigned to an editor这个是啥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cdc09126193, createdName=ms2000000089409289, createdTime=Thu Feb 29 14:55:03 CST 2024, time=2024-02-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2146816, encodeId=a52d21468164a, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：这个杂志真是个神，1月投稿，4月拿到一个审稿人意见，然后现在7月了，还是一个审稿人，额，6个月了，就这，不知道要多久，催了也没用，这杂志牛的，我估计年底给我意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95fa1958473, createdName=presson, createdTime=Fri Jul 07 16:01:50 CST 2023, time=2023-07-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1234686, encodeId=c069123468672, content=1 Reviewer report received一般要等多久啊。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2665416535, createdName=一路同行, createdTime=Mon Jul 25 19:49:16 CST 2022, time=2022-07-25, status=1, ipAttribution=)]

2022-05-10 ms2000000426385162

请教各位，进入Amendment requested状态，通讯作者没有收到修改的邮件，给编辑发邮件询问已经过去四天了，没有回复，系统给了十天修改，还剩五天了。请问有没有人遇到这种情况的，到底怎么解决，我看期刊给的有个电话，有人打过这个电话吗？马上面临毕业了，非常着急！！！

210 13

展开13条回复

[GetPortalCommentsPageByObjectIdResponse(id=2125935, encodeId=18f121259355f, content=指派编辑以后Peer review要几天呢？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Fri Apr 14 16:32:58 CST 2023, time=2023-04-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=600264, encodeId=c43f6002643b, content=经验分享：去年12月初投稿，一审近2个月，大修，3位审稿专家提了好几个问题，都很专业，补了2个实验，没有办法补的实验就解释了一下。疫情原因试剂盒到位慢，申请延期1个月，二审1个半月，直接接收。一审二审都有形式审查，大约在投稿后一周左右给第一作者邮件反馈。decision letter直接发给通讯作者，其他作者看不到。另，感觉该杂志现在并不容易发表，审稿人问题有的也很尖锐，不知道为什么大家对它有偏见？这次遇到的审稿专家都还nice，没再让修改，心存感激。以上仅为个人观点，供大家参考，祝好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=482, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/59f804c69cf94ad1ab29dcfd6d74999a/ba623a930dae4fd7a8548c91ceb5dfcf.jpg, createdBy=82a72227743, createdName=meimary, createdTime=Sun May 24 12:13:23 CST 2020, time=2020-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218426, encodeId=06fb1218426a6, content=请教各位，进入Amendment requested状态，通讯作者没有收到修改的邮件，给编辑发邮件询问已经过去四天了，没有回复，系统给了十天修改，还剩五天了。请问有没有人遇到这种情况的，到底怎么解决，我看期刊给的有个电话，有人打过这个电话吗？马上面临毕业了，非常着急！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b155628254, createdName=ms2000000426385162, createdTime=Tue May 10 12:55:16 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203369, encodeId=7080120336979, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：乳腺癌;生信 经验分享：各位大神，你们的Response letter提交后多久有消息啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c4a02291457, createdName=wjsw123, createdTime=Thu Mar 17 09:24:21 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946858, encodeId=cb0994685829, content=proof后一般多久出版？我的两周了没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11753055294, createdName=gzbh, createdTime=Tue Mar 09 17:50:13 CST 2021, time=2021-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2178836, encodeId=212721e883660, content=偏重的研究方向：生物信息学;肿瘤;Cancer 经验分享：- [ ] 2023.12.26 submission received - [ ] 2023.12.26 submission is under technical check - [ ] 2023.12.27 submission passed technical check - [ ] 2023.12.27 editor invited - [ ] 2023.12.27 editor assigned - [ ] 2023.12.27 reviewers invited(3) - [ ] 2023.12.27 1 reviewer(s) accepted - [ ] 2023.12.30 2 reviewer(s) accepted (Awaiting their report), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240102/21c3548d3cdf4d768708708330c1b141/805c04b8c592400eb28358eb81f1a145.jpg, createdBy=4a299119890, createdName=Dehors, createdTime=Tue Jan 02 18:33:59 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2189047, encodeId=5931218904edb, content=偏重的研究方向：生物信息学 经验分享：<a href='/topic/show?id=8d82e952353' target=_blank style='color:#2F92EE;'>#网络药理学#</a>一个审稿人，等待编辑决定中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=12, topicName=null, topicId=null, topicList=[TopicDto(id=79523, encryptionId=8d82e952353, topicName=网络药理学)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae475506057, createdName=zll2020, createdTime=Sat Feb 24 11:25:52 CST 2024, time=2024-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190100, encodeId=2ddb2190100ee, content=Ready to be assigned to an editor这个是啥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cdc09126193, createdName=ms2000000089409289, createdTime=Thu Feb 29 14:55:03 CST 2024, time=2024-02-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2146816, encodeId=a52d21468164a, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：这个杂志真是个神，1月投稿，4月拿到一个审稿人意见，然后现在7月了，还是一个审稿人，额，6个月了，就这，不知道要多久，催了也没用，这杂志牛的，我估计年底给我意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95fa1958473, createdName=presson, createdTime=Fri Jul 07 16:01:50 CST 2023, time=2023-07-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1234686, encodeId=c069123468672, content=1 Reviewer report received一般要等多久啊。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2665416535, createdName=一路同行, createdTime=Mon Jul 25 19:49:16 CST 2022, time=2022-07-25, status=1, ipAttribution=)]

2022-03-17 wjsw123

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：乳腺癌;生信
经验分享：各位大神，你们的Response letter提交后多久有消息啊？

4 13

展开13条回复

[GetPortalCommentsPageByObjectIdResponse(id=2125935, encodeId=18f121259355f, content=指派编辑以后Peer review要几天呢？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Fri Apr 14 16:32:58 CST 2023, time=2023-04-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=600264, encodeId=c43f6002643b, content=经验分享：去年12月初投稿，一审近2个月，大修，3位审稿专家提了好几个问题，都很专业，补了2个实验，没有办法补的实验就解释了一下。疫情原因试剂盒到位慢，申请延期1个月，二审1个半月，直接接收。一审二审都有形式审查，大约在投稿后一周左右给第一作者邮件反馈。decision letter直接发给通讯作者，其他作者看不到。另，感觉该杂志现在并不容易发表，审稿人问题有的也很尖锐，不知道为什么大家对它有偏见？这次遇到的审稿专家都还nice，没再让修改，心存感激。以上仅为个人观点，供大家参考，祝好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=482, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/59f804c69cf94ad1ab29dcfd6d74999a/ba623a930dae4fd7a8548c91ceb5dfcf.jpg, createdBy=82a72227743, createdName=meimary, createdTime=Sun May 24 12:13:23 CST 2020, time=2020-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218426, encodeId=06fb1218426a6, content=请教各位，进入Amendment requested状态，通讯作者没有收到修改的邮件，给编辑发邮件询问已经过去四天了，没有回复，系统给了十天修改，还剩五天了。请问有没有人遇到这种情况的，到底怎么解决，我看期刊给的有个电话，有人打过这个电话吗？马上面临毕业了，非常着急！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b155628254, createdName=ms2000000426385162, createdTime=Tue May 10 12:55:16 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203369, encodeId=7080120336979, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：乳腺癌;生信 经验分享：各位大神，你们的Response letter提交后多久有消息啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c4a02291457, createdName=wjsw123, createdTime=Thu Mar 17 09:24:21 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946858, encodeId=cb0994685829, content=proof后一般多久出版？我的两周了没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11753055294, createdName=gzbh, createdTime=Tue Mar 09 17:50:13 CST 2021, time=2021-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2178836, encodeId=212721e883660, content=偏重的研究方向：生物信息学;肿瘤;Cancer 经验分享：- [ ] 2023.12.26 submission received - [ ] 2023.12.26 submission is under technical check - [ ] 2023.12.27 submission passed technical check - [ ] 2023.12.27 editor invited - [ ] 2023.12.27 editor assigned - [ ] 2023.12.27 reviewers invited(3) - [ ] 2023.12.27 1 reviewer(s) accepted - [ ] 2023.12.30 2 reviewer(s) accepted (Awaiting their report), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240102/21c3548d3cdf4d768708708330c1b141/805c04b8c592400eb28358eb81f1a145.jpg, createdBy=4a299119890, createdName=Dehors, createdTime=Tue Jan 02 18:33:59 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2189047, encodeId=5931218904edb, content=偏重的研究方向：生物信息学 经验分享：<a href='/topic/show?id=8d82e952353' target=_blank style='color:#2F92EE;'>#网络药理学#</a>一个审稿人，等待编辑决定中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=12, topicName=null, topicId=null, topicList=[TopicDto(id=79523, encryptionId=8d82e952353, topicName=网络药理学)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae475506057, createdName=zll2020, createdTime=Sat Feb 24 11:25:52 CST 2024, time=2024-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190100, encodeId=2ddb2190100ee, content=Ready to be assigned to an editor这个是啥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cdc09126193, createdName=ms2000000089409289, createdTime=Thu Feb 29 14:55:03 CST 2024, time=2024-02-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2146816, encodeId=a52d21468164a, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：这个杂志真是个神，1月投稿，4月拿到一个审稿人意见，然后现在7月了，还是一个审稿人，额，6个月了，就这，不知道要多久，催了也没用，这杂志牛的，我估计年底给我意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95fa1958473, createdName=presson, createdTime=Fri Jul 07 16:01:50 CST 2023, time=2023-07-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1234686, encodeId=c069123468672, content=1 Reviewer report received一般要等多久啊。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2665416535, createdName=一路同行, createdTime=Mon Jul 25 19:49:16 CST 2022, time=2022-07-25, status=1, ipAttribution=)]

2021-03-09 gzbh

proof后一般多久出版？我的两周了没动静

112 13

展开13条回复

[GetPortalCommentsPageByObjectIdResponse(id=2125935, encodeId=18f121259355f, content=指派编辑以后Peer review要几天呢？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Fri Apr 14 16:32:58 CST 2023, time=2023-04-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=600264, encodeId=c43f6002643b, content=经验分享：去年12月初投稿，一审近2个月，大修，3位审稿专家提了好几个问题，都很专业，补了2个实验，没有办法补的实验就解释了一下。疫情原因试剂盒到位慢，申请延期1个月，二审1个半月，直接接收。一审二审都有形式审查，大约在投稿后一周左右给第一作者邮件反馈。decision letter直接发给通讯作者，其他作者看不到。另，感觉该杂志现在并不容易发表，审稿人问题有的也很尖锐，不知道为什么大家对它有偏见？这次遇到的审稿专家都还nice，没再让修改，心存感激。以上仅为个人观点，供大家参考，祝好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=482, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/59f804c69cf94ad1ab29dcfd6d74999a/ba623a930dae4fd7a8548c91ceb5dfcf.jpg, createdBy=82a72227743, createdName=meimary, createdTime=Sun May 24 12:13:23 CST 2020, time=2020-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218426, encodeId=06fb1218426a6, content=请教各位，进入Amendment requested状态，通讯作者没有收到修改的邮件，给编辑发邮件询问已经过去四天了，没有回复，系统给了十天修改，还剩五天了。请问有没有人遇到这种情况的，到底怎么解决，我看期刊给的有个电话，有人打过这个电话吗？马上面临毕业了，非常着急！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b155628254, createdName=ms2000000426385162, createdTime=Tue May 10 12:55:16 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203369, encodeId=7080120336979, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：乳腺癌;生信 经验分享：各位大神，你们的Response letter提交后多久有消息啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c4a02291457, createdName=wjsw123, createdTime=Thu Mar 17 09:24:21 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946858, encodeId=cb0994685829, content=proof后一般多久出版？我的两周了没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11753055294, createdName=gzbh, createdTime=Tue Mar 09 17:50:13 CST 2021, time=2021-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2178836, encodeId=212721e883660, content=偏重的研究方向：生物信息学;肿瘤;Cancer 经验分享：- [ ] 2023.12.26 submission received - [ ] 2023.12.26 submission is under technical check - [ ] 2023.12.27 submission passed technical check - [ ] 2023.12.27 editor invited - [ ] 2023.12.27 editor assigned - [ ] 2023.12.27 reviewers invited(3) - [ ] 2023.12.27 1 reviewer(s) accepted - [ ] 2023.12.30 2 reviewer(s) accepted (Awaiting their report), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240102/21c3548d3cdf4d768708708330c1b141/805c04b8c592400eb28358eb81f1a145.jpg, createdBy=4a299119890, createdName=Dehors, createdTime=Tue Jan 02 18:33:59 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2189047, encodeId=5931218904edb, content=偏重的研究方向：生物信息学 经验分享：<a href='/topic/show?id=8d82e952353' target=_blank style='color:#2F92EE;'>#网络药理学#</a>一个审稿人，等待编辑决定中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=12, topicName=null, topicId=null, topicList=[TopicDto(id=79523, encryptionId=8d82e952353, topicName=网络药理学)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae475506057, createdName=zll2020, createdTime=Sat Feb 24 11:25:52 CST 2024, time=2024-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190100, encodeId=2ddb2190100ee, content=Ready to be assigned to an editor这个是啥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cdc09126193, createdName=ms2000000089409289, createdTime=Thu Feb 29 14:55:03 CST 2024, time=2024-02-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2146816, encodeId=a52d21468164a, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：这个杂志真是个神，1月投稿，4月拿到一个审稿人意见，然后现在7月了，还是一个审稿人，额，6个月了，就这，不知道要多久，催了也没用，这杂志牛的，我估计年底给我意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95fa1958473, createdName=presson, createdTime=Fri Jul 07 16:01:50 CST 2023, time=2023-07-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1234686, encodeId=c069123468672, content=1 Reviewer report received一般要等多久啊。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2665416535, createdName=一路同行, createdTime=Mon Jul 25 19:49:16 CST 2022, time=2022-07-25, status=1, ipAttribution=)]

2024-01-02 Dehors 来自江苏省

偏重的研究方向：生物信息学;肿瘤;Cancer
经验分享：- [ ] 2023.12.26 submission received - [ ] 2023.12.26 submission is under technical check - [ ] 2023.12.27 submission passed technical check - [ ] 2023.12.27 editor invited - [ ] 2023.12.27 editor assigned - [ ] 2023.12.27 reviewers invited(3) - [ ] 2023.12.27 1 reviewer(s) accepted - [ ] 2023.12.30 2 reviewer(s) accepted (Awaiting their report)

66 12

展开12条回复

[GetPortalCommentsPageByObjectIdResponse(id=2125935, encodeId=18f121259355f, content=指派编辑以后Peer review要几天呢？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Fri Apr 14 16:32:58 CST 2023, time=2023-04-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=600264, encodeId=c43f6002643b, content=经验分享：去年12月初投稿，一审近2个月，大修，3位审稿专家提了好几个问题，都很专业，补了2个实验，没有办法补的实验就解释了一下。疫情原因试剂盒到位慢，申请延期1个月，二审1个半月，直接接收。一审二审都有形式审查，大约在投稿后一周左右给第一作者邮件反馈。decision letter直接发给通讯作者，其他作者看不到。另，感觉该杂志现在并不容易发表，审稿人问题有的也很尖锐，不知道为什么大家对它有偏见？这次遇到的审稿专家都还nice，没再让修改，心存感激。以上仅为个人观点，供大家参考，祝好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=482, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/59f804c69cf94ad1ab29dcfd6d74999a/ba623a930dae4fd7a8548c91ceb5dfcf.jpg, createdBy=82a72227743, createdName=meimary, createdTime=Sun May 24 12:13:23 CST 2020, time=2020-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218426, encodeId=06fb1218426a6, content=请教各位，进入Amendment requested状态，通讯作者没有收到修改的邮件，给编辑发邮件询问已经过去四天了，没有回复，系统给了十天修改，还剩五天了。请问有没有人遇到这种情况的，到底怎么解决，我看期刊给的有个电话，有人打过这个电话吗？马上面临毕业了，非常着急！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b155628254, createdName=ms2000000426385162, createdTime=Tue May 10 12:55:16 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203369, encodeId=7080120336979, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：乳腺癌;生信 经验分享：各位大神，你们的Response letter提交后多久有消息啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c4a02291457, createdName=wjsw123, createdTime=Thu Mar 17 09:24:21 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946858, encodeId=cb0994685829, content=proof后一般多久出版？我的两周了没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11753055294, createdName=gzbh, createdTime=Tue Mar 09 17:50:13 CST 2021, time=2021-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2178836, encodeId=212721e883660, content=偏重的研究方向：生物信息学;肿瘤;Cancer 经验分享：- [ ] 2023.12.26 submission received - [ ] 2023.12.26 submission is under technical check - [ ] 2023.12.27 submission passed technical check - [ ] 2023.12.27 editor invited - [ ] 2023.12.27 editor assigned - [ ] 2023.12.27 reviewers invited(3) - [ ] 2023.12.27 1 reviewer(s) accepted - [ ] 2023.12.30 2 reviewer(s) accepted (Awaiting their report), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240102/21c3548d3cdf4d768708708330c1b141/805c04b8c592400eb28358eb81f1a145.jpg, createdBy=4a299119890, createdName=Dehors, createdTime=Tue Jan 02 18:33:59 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2189047, encodeId=5931218904edb, content=偏重的研究方向：生物信息学 经验分享：<a href='/topic/show?id=8d82e952353' target=_blank style='color:#2F92EE;'>#网络药理学#</a>一个审稿人，等待编辑决定中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=12, topicName=null, topicId=null, topicList=[TopicDto(id=79523, encryptionId=8d82e952353, topicName=网络药理学)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae475506057, createdName=zll2020, createdTime=Sat Feb 24 11:25:52 CST 2024, time=2024-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190100, encodeId=2ddb2190100ee, content=Ready to be assigned to an editor这个是啥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cdc09126193, createdName=ms2000000089409289, createdTime=Thu Feb 29 14:55:03 CST 2024, time=2024-02-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2146816, encodeId=a52d21468164a, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：这个杂志真是个神，1月投稿，4月拿到一个审稿人意见，然后现在7月了，还是一个审稿人，额，6个月了，就这，不知道要多久，催了也没用，这杂志牛的，我估计年底给我意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95fa1958473, createdName=presson, createdTime=Fri Jul 07 16:01:50 CST 2023, time=2023-07-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1234686, encodeId=c069123468672, content=1 Reviewer report received一般要等多久啊。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2665416535, createdName=一路同行, createdTime=Mon Jul 25 19:49:16 CST 2022, time=2022-07-25, status=1, ipAttribution=)]

2024-02-24 zll2020 来自四川省

偏重的研究方向：生物信息学
经验分享：#网络药理学#一个审稿人，等待编辑决定中

73 12

展开12条回复

[GetPortalCommentsPageByObjectIdResponse(id=2125935, encodeId=18f121259355f, content=指派编辑以后Peer review要几天呢？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Fri Apr 14 16:32:58 CST 2023, time=2023-04-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=600264, encodeId=c43f6002643b, content=经验分享：去年12月初投稿，一审近2个月，大修，3位审稿专家提了好几个问题，都很专业，补了2个实验，没有办法补的实验就解释了一下。疫情原因试剂盒到位慢，申请延期1个月，二审1个半月，直接接收。一审二审都有形式审查，大约在投稿后一周左右给第一作者邮件反馈。decision letter直接发给通讯作者，其他作者看不到。另，感觉该杂志现在并不容易发表，审稿人问题有的也很尖锐，不知道为什么大家对它有偏见？这次遇到的审稿专家都还nice，没再让修改，心存感激。以上仅为个人观点，供大家参考，祝好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=482, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/59f804c69cf94ad1ab29dcfd6d74999a/ba623a930dae4fd7a8548c91ceb5dfcf.jpg, createdBy=82a72227743, createdName=meimary, createdTime=Sun May 24 12:13:23 CST 2020, time=2020-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218426, encodeId=06fb1218426a6, content=请教各位，进入Amendment requested状态，通讯作者没有收到修改的邮件，给编辑发邮件询问已经过去四天了，没有回复，系统给了十天修改，还剩五天了。请问有没有人遇到这种情况的，到底怎么解决，我看期刊给的有个电话，有人打过这个电话吗？马上面临毕业了，非常着急！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b155628254, createdName=ms2000000426385162, createdTime=Tue May 10 12:55:16 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203369, encodeId=7080120336979, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：乳腺癌;生信 经验分享：各位大神，你们的Response letter提交后多久有消息啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c4a02291457, createdName=wjsw123, createdTime=Thu Mar 17 09:24:21 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946858, encodeId=cb0994685829, content=proof后一般多久出版？我的两周了没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11753055294, createdName=gzbh, createdTime=Tue Mar 09 17:50:13 CST 2021, time=2021-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2178836, encodeId=212721e883660, content=偏重的研究方向：生物信息学;肿瘤;Cancer 经验分享：- [ ] 2023.12.26 submission received - [ ] 2023.12.26 submission is under technical check - [ ] 2023.12.27 submission passed technical check - [ ] 2023.12.27 editor invited - [ ] 2023.12.27 editor assigned - [ ] 2023.12.27 reviewers invited(3) - [ ] 2023.12.27 1 reviewer(s) accepted - [ ] 2023.12.30 2 reviewer(s) accepted (Awaiting their report), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240102/21c3548d3cdf4d768708708330c1b141/805c04b8c592400eb28358eb81f1a145.jpg, createdBy=4a299119890, createdName=Dehors, createdTime=Tue Jan 02 18:33:59 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2189047, encodeId=5931218904edb, content=偏重的研究方向：生物信息学 经验分享：<a href='/topic/show?id=8d82e952353' target=_blank style='color:#2F92EE;'>#网络药理学#</a>一个审稿人，等待编辑决定中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=12, topicName=null, topicId=null, topicList=[TopicDto(id=79523, encryptionId=8d82e952353, topicName=网络药理学)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae475506057, createdName=zll2020, createdTime=Sat Feb 24 11:25:52 CST 2024, time=2024-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190100, encodeId=2ddb2190100ee, content=Ready to be assigned to an editor这个是啥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cdc09126193, createdName=ms2000000089409289, createdTime=Thu Feb 29 14:55:03 CST 2024, time=2024-02-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2146816, encodeId=a52d21468164a, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：这个杂志真是个神，1月投稿，4月拿到一个审稿人意见，然后现在7月了，还是一个审稿人，额，6个月了，就这，不知道要多久，催了也没用，这杂志牛的，我估计年底给我意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95fa1958473, createdName=presson, createdTime=Fri Jul 07 16:01:50 CST 2023, time=2023-07-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1234686, encodeId=c069123468672, content=1 Reviewer report received一般要等多久啊。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2665416535, createdName=一路同行, createdTime=Mon Jul 25 19:49:16 CST 2022, time=2022-07-25, status=1, ipAttribution=)]

2024-02-29 ms2000000089409289 来自江西省

Ready to be assigned to an editor这个是啥

70 12

展开12条回复

[GetPortalCommentsPageByObjectIdResponse(id=2125935, encodeId=18f121259355f, content=指派编辑以后Peer review要几天呢？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Fri Apr 14 16:32:58 CST 2023, time=2023-04-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=600264, encodeId=c43f6002643b, content=经验分享：去年12月初投稿，一审近2个月，大修，3位审稿专家提了好几个问题，都很专业，补了2个实验，没有办法补的实验就解释了一下。疫情原因试剂盒到位慢，申请延期1个月，二审1个半月，直接接收。一审二审都有形式审查，大约在投稿后一周左右给第一作者邮件反馈。decision letter直接发给通讯作者，其他作者看不到。另，感觉该杂志现在并不容易发表，审稿人问题有的也很尖锐，不知道为什么大家对它有偏见？这次遇到的审稿专家都还nice，没再让修改，心存感激。以上仅为个人观点，供大家参考，祝好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=482, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/59f804c69cf94ad1ab29dcfd6d74999a/ba623a930dae4fd7a8548c91ceb5dfcf.jpg, createdBy=82a72227743, createdName=meimary, createdTime=Sun May 24 12:13:23 CST 2020, time=2020-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218426, encodeId=06fb1218426a6, content=请教各位，进入Amendment requested状态，通讯作者没有收到修改的邮件，给编辑发邮件询问已经过去四天了，没有回复，系统给了十天修改，还剩五天了。请问有没有人遇到这种情况的，到底怎么解决，我看期刊给的有个电话，有人打过这个电话吗？马上面临毕业了，非常着急！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b155628254, createdName=ms2000000426385162, createdTime=Tue May 10 12:55:16 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203369, encodeId=7080120336979, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：乳腺癌;生信 经验分享：各位大神，你们的Response letter提交后多久有消息啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c4a02291457, createdName=wjsw123, createdTime=Thu Mar 17 09:24:21 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946858, encodeId=cb0994685829, content=proof后一般多久出版？我的两周了没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11753055294, createdName=gzbh, createdTime=Tue Mar 09 17:50:13 CST 2021, time=2021-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2178836, encodeId=212721e883660, content=偏重的研究方向：生物信息学;肿瘤;Cancer 经验分享：- [ ] 2023.12.26 submission received - [ ] 2023.12.26 submission is under technical check - [ ] 2023.12.27 submission passed technical check - [ ] 2023.12.27 editor invited - [ ] 2023.12.27 editor assigned - [ ] 2023.12.27 reviewers invited(3) - [ ] 2023.12.27 1 reviewer(s) accepted - [ ] 2023.12.30 2 reviewer(s) accepted (Awaiting their report), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240102/21c3548d3cdf4d768708708330c1b141/805c04b8c592400eb28358eb81f1a145.jpg, createdBy=4a299119890, createdName=Dehors, createdTime=Tue Jan 02 18:33:59 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2189047, encodeId=5931218904edb, content=偏重的研究方向：生物信息学 经验分享：<a href='/topic/show?id=8d82e952353' target=_blank style='color:#2F92EE;'>#网络药理学#</a>一个审稿人，等待编辑决定中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=12, topicName=null, topicId=null, topicList=[TopicDto(id=79523, encryptionId=8d82e952353, topicName=网络药理学)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae475506057, createdName=zll2020, createdTime=Sat Feb 24 11:25:52 CST 2024, time=2024-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190100, encodeId=2ddb2190100ee, content=Ready to be assigned to an editor这个是啥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cdc09126193, createdName=ms2000000089409289, createdTime=Thu Feb 29 14:55:03 CST 2024, time=2024-02-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2146816, encodeId=a52d21468164a, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：这个杂志真是个神，1月投稿，4月拿到一个审稿人意见，然后现在7月了，还是一个审稿人，额，6个月了，就这，不知道要多久，催了也没用，这杂志牛的，我估计年底给我意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95fa1958473, createdName=presson, createdTime=Fri Jul 07 16:01:50 CST 2023, time=2023-07-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1234686, encodeId=c069123468672, content=1 Reviewer report received一般要等多久啊。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2665416535, createdName=一路同行, createdTime=Mon Jul 25 19:49:16 CST 2022, time=2022-07-25, status=1, ipAttribution=)]

2023-07-07 presson 来自上海

审稿速度:12.0 | 投稿命中率:50.0
经验分享：这个杂志真是个神，1月投稿，4月拿到一个审稿人意见，然后现在7月了，还是一个审稿人，额，6个月了，就这，不知道要多久，催了也没用，这杂志牛的，我估计年底给我意见

111 12

展开12条回复

[GetPortalCommentsPageByObjectIdResponse(id=2125935, encodeId=18f121259355f, content=指派编辑以后Peer review要几天呢？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Fri Apr 14 16:32:58 CST 2023, time=2023-04-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=600264, encodeId=c43f6002643b, content=经验分享：去年12月初投稿，一审近2个月，大修，3位审稿专家提了好几个问题，都很专业，补了2个实验，没有办法补的实验就解释了一下。疫情原因试剂盒到位慢，申请延期1个月，二审1个半月，直接接收。一审二审都有形式审查，大约在投稿后一周左右给第一作者邮件反馈。decision letter直接发给通讯作者，其他作者看不到。另，感觉该杂志现在并不容易发表，审稿人问题有的也很尖锐，不知道为什么大家对它有偏见？这次遇到的审稿专家都还nice，没再让修改，心存感激。以上仅为个人观点，供大家参考，祝好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=482, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/59f804c69cf94ad1ab29dcfd6d74999a/ba623a930dae4fd7a8548c91ceb5dfcf.jpg, createdBy=82a72227743, createdName=meimary, createdTime=Sun May 24 12:13:23 CST 2020, time=2020-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218426, encodeId=06fb1218426a6, content=请教各位，进入Amendment requested状态，通讯作者没有收到修改的邮件，给编辑发邮件询问已经过去四天了，没有回复，系统给了十天修改，还剩五天了。请问有没有人遇到这种情况的，到底怎么解决，我看期刊给的有个电话，有人打过这个电话吗？马上面临毕业了，非常着急！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b155628254, createdName=ms2000000426385162, createdTime=Tue May 10 12:55:16 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203369, encodeId=7080120336979, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：乳腺癌;生信 经验分享：各位大神，你们的Response letter提交后多久有消息啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c4a02291457, createdName=wjsw123, createdTime=Thu Mar 17 09:24:21 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946858, encodeId=cb0994685829, content=proof后一般多久出版？我的两周了没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11753055294, createdName=gzbh, createdTime=Tue Mar 09 17:50:13 CST 2021, time=2021-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2178836, encodeId=212721e883660, content=偏重的研究方向：生物信息学;肿瘤;Cancer 经验分享：- [ ] 2023.12.26 submission received - [ ] 2023.12.26 submission is under technical check - [ ] 2023.12.27 submission passed technical check - [ ] 2023.12.27 editor invited - [ ] 2023.12.27 editor assigned - [ ] 2023.12.27 reviewers invited(3) - [ ] 2023.12.27 1 reviewer(s) accepted - [ ] 2023.12.30 2 reviewer(s) accepted (Awaiting their report), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240102/21c3548d3cdf4d768708708330c1b141/805c04b8c592400eb28358eb81f1a145.jpg, createdBy=4a299119890, createdName=Dehors, createdTime=Tue Jan 02 18:33:59 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2189047, encodeId=5931218904edb, content=偏重的研究方向：生物信息学 经验分享：<a href='/topic/show?id=8d82e952353' target=_blank style='color:#2F92EE;'>#网络药理学#</a>一个审稿人，等待编辑决定中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=12, topicName=null, topicId=null, topicList=[TopicDto(id=79523, encryptionId=8d82e952353, topicName=网络药理学)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae475506057, createdName=zll2020, createdTime=Sat Feb 24 11:25:52 CST 2024, time=2024-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190100, encodeId=2ddb2190100ee, content=Ready to be assigned to an editor这个是啥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cdc09126193, createdName=ms2000000089409289, createdTime=Thu Feb 29 14:55:03 CST 2024, time=2024-02-29, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2146816, encodeId=a52d21468164a, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：这个杂志真是个神，1月投稿，4月拿到一个审稿人意见，然后现在7月了，还是一个审稿人，额，6个月了，就这，不知道要多久，催了也没用，这杂志牛的，我估计年底给我意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95fa1958473, createdName=presson, createdTime=Fri Jul 07 16:01:50 CST 2023, time=2023-07-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1234686, encodeId=c069123468672, content=1 Reviewer report received一般要等多久啊。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2665416535, createdName=一路同行, createdTime=Mon Jul 25 19:49:16 CST 2022, time=2022-07-25, status=1, ipAttribution=)]

2022-07-25 一路同行

1 Reviewer report received一般要等多久啊。。。

44 12

展开12条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务